🖤CAGRILINTIDE

Cagrilintide

Cagrilintide is a long-acting synthetic amylin analog supplied in lyophilized form for controlled laboratory, analytical, and scientific research. It is a chemically modified peptide designed for experimental investigation involving peptide characterization, receptor interactions, molecular signaling, stability, and structure–activity relationships.

Cagrilintide is a relatively large modified peptide containing a disulfide bridge and lipid modification. PubChem identifies it under CID 171397054, with CAS 1415456-99-3, molecular formula C194H312N54O59S2, and molecular weight approximately 4409 g/mol.

Product Specifications

Product Name: Cagrilintide
Quantity: 5 mg
Classification: Long-acting synthetic amylin analog
Form: Lyophilized peptide powder
Peptide Type: Chemically modified research peptide
Purity: Refer to batch-specific Certificate of Analysis
Intended Use: Laboratory and analytical research only

Storage

Store lyophilized research material under controlled, cool, dry conditions and protect from direct light and moisture. Exact storage requirements should follow the applicable batch-specific Certificate of Analysis, particularly because peptide formulation and salt form can affect stability.

Research-Only Use

This material is supplied strictly for laboratory, analytical, and in vitro research use only. It is not intended for human consumption, clinical administration, diagnostic procedures, or veterinary applications.

Disclaimer

The information presented here is provided solely for scientific, analytical, and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease. Cagrilintide remains an investigational compound and should be handled only in appropriate research environments.

Terms of Sale

By purchasing this research material, the purchaser confirms responsibility for proper handling, storage, use, and disposal according to applicable laboratory procedures and requirements.

About Cagrilintide

Cagrilintide is a chemically engineered analog of amylin, a peptide hormone used as the structural basis for this investigational research compound. Published structural work describes Cagrilintide as a long-acting amylin analog containing sequence modifications intended to alter its molecular and pharmacological characteristics.

Its structure includes a modified peptide sequence, a Cys–Cys disulfide linkage, and lipid-related chemical modification. These features distinguish Cagrilintide from simpler unmodified research peptides.

Research Focus

Laboratory investigation involving Cagrilintide may include:

• Amylin-receptor interaction research
• Peptide characterization
• Structure–activity studies
• Receptor-binding investigations
• Molecular signaling research
• Modified-peptide stability studies
• Chromatographic characterization
• Mass-spectrometry verification
• Analytical identification
• Formulation studies
• Batch-specific purity verification

Molecular Characteristics

Product Name: Cagrilintide
CAS Number: 1415456-99-3
PubChem CID: 171397054
UNII: AO43BIF1U8
ChEMBL ID: CHEMBL4802169
DrugBank ID: DB18887
Molecular Formula: C194H312N54O59S2
Molecular Weight: 4409 g/mol
Exact Mass: 4408.2582 Da
Classification: Long-acting synthetic amylin analog / modified peptide.

PubChem represents the biologic sequence as:

XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP

The initial X reflects a chemically modified portion of the molecule rather than a standard amino-acid residue. Published structural descriptions also document the cyclic disulfide component and additional chemical modification of the peptide.

Research Status

Cagrilintide remains an investigational compound. PubChem currently identifies it as a long-acting amylin analog and notes ongoing clinical investigation; this does not make research-grade material an approved therapeutic product.

For the AVM product, the applicable Certificate of Analysis should remain the controlling reference for the exact supplied form, identity, purity, and analytical characteristics.

AVM Labs USA Research Standard

AVM Labs USA supplies Cagrilintide 5 mg exclusively for laboratory, analytical, and scientific research purposes.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. NOT INTENDED FOR CONSUMPTION, DIAGNOSIS, TREATMENT, CURE, OR PREVENTION OF ANY DISEASE.